Fantastic appraisal. I think dig got a bad rap when this trial came out (I was still a trainee back in the day). As a result, I used it seldomly for quite some time. I’ve reincorporated it back into the tool box in recent years for the purposes of reducing hospitalizations, although I still avoid in CKD, rarely go to 0.25 mg daily, and do tend to check levels. I also use it more often in AF/CHF, recognizing that this was an exclusion in this trial, but in my experience has provided for useful two-fer benefits.
Fantastic appraisal. I think dig got a bad rap when this trial came out (I was still a trainee back in the day). As a result, I used it seldomly for quite some time. I’ve reincorporated it back into the tool box in recent years for the purposes of reducing hospitalizations, although I still avoid in CKD, rarely go to 0.25 mg daily, and do tend to check levels. I also use it more often in AF/CHF, recognizing that this was an exclusion in this trial, but in my experience has provided for useful two-fer benefits.
thank you... do docs use this in part of an overall protocol in standard practice?
Dig is used much less frequently compared to before. We discussed this on our podcast to be published this Friday!